COMPANIES COVERED
Pfizer, Inc.Download FREE Report Sample
Download Free sampleChronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function.
Chronic Kidney Disease Drugs Market contains market size and forecasts of Chronic Kidney Disease (CKD) Drugs in global, including the following market information:
Global Chronic Kidney Disease (CKD) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Kidney Disease (CKD) Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chronic Kidney Disease (CKD) Drugs companies in 2021 (%)
The global Chronic Kidney Disease (CKD) Drugs market was valued at 14390 million in 2021 and is projected to reach US$ 16070 million by 2028, at a CAGR of 1.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ACE Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Kidney Disease (CKD) Drugs include Pfizer, Inc., Amgen, Roche, GlaxoSmithKline (GSK), Allergan, AbbVie and Kissei Pharmaceutical Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Wesurveyed the Chronic Kidney Disease (CKD) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Kidney Disease (CKD) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chronic Kidney Disease (CKD) Drugs Market Segment Percentages, by Type, 2021 (%)
ACE Inhibitors
Angiotensin-II Receptor Blockers
Calcium Channel Blockers
Beta Blockers: BREVIBLOC, Bystolic
Others
Global Chronic Kidney Disease (CKD) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chronic Kidney Disease (CKD) Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Global Chronic Kidney Disease (CKD) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chronic Kidney Disease (CKD) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Kidney Disease (CKD) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Kidney Disease (CKD) Drugs revenues share in global market, 2021 (%)
Key companies Chronic Kidney Disease (CKD) Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chronic Kidney Disease (CKD) Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Amgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical Co., Ltd.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
